Cody McKenzie of Glaukos discusses the impact of the iDose TR at the ASCRS meeting. He announces that the travoprost intracameral implant received a permanent J-code, J7355, from CMS for reducing IOP in open-angle glaucoma or ocular hypertension, effective July 1. This will increase patient access and streamline claims processing. McKenzie, the vice president and franchise head of glaucoma at Glaukos, highlights the importance of this development in the field of ophthalmology.
Source link
iDose TR launches, receives permanent J-code
